tradingkey.logo
tradingkey.logo
Search

Microbot Medical Inc

MBOT
Add to Watchlist
1.720USD
-0.020-1.15%
Close 07-31 16:00ETQuotes delayed by 15 min
115.51MMarket Cap
LossP/E TTM

Microbot Medical Inc

1.720
-0.020-1.15%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.15%

5 Days

+0.58%

1 Month

-9.95%

6 Months

-4.44%

Year to Date

-14.00%

1 Year

-32.55%

Key Figures
1.750Open
1.760High
311.39KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.46%Turnover Ratio
1.740Prev. Close
1.680Low
392.90KTurnover
LossP/E Static
1.56P/B
0.00%Div Yield TTM
-26.09%ROA
4.67052wk High
0.62Volume Ratio
-11.44MNet Profit
67.16MShares
-0.2580EPS TTM
1.03Beta
-27.58%ROE
1.60052wk Low
4.60%Amplitude
1.90%Gross Margin
115.51MMarket Cap
-2.44Reward/Risk
4.03%Risk Rate

TradingKey Stock Score of Microbot Medical Inc

Currency: USD Updated: 2026-07-31

Key Insights

Microbot Medical Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 129 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.00.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Microbot Medical Inc's Score

Industry at a Glance

Industry Ranking
129 / 385
Overall Ranking
212 / 4281
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Microbot Medical Inc Highlights

StrengthsRisks
Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 0.00.
Undervalued
The company’s latest PE is -6.67, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 15.51M shares, increasing 25.62% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 352.34 shares of this stock.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
7.000
Target Price
+319.16%
Upside Space

Microbot Medical Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 3 analysts
Buy
Current Rating
7.000
Target Price
+319.16%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Microbot Medical Inc
MBOT
3
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99

Indicators

Indicators
Sell(3)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-0.014
Sell
RSI(14)
41.569
Neutral
STOCH(KDJ)(9,3,3)
34.942
Buy
ATR(14)
0.068
High Vlolatility
CCI(14)
-65.782
Neutral
Williams %R
72.000
Sell
TRIX(12,20)
-0.348
Sell
StochRSI(14)
80.587
Buy
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
1.710
Buy
MA10
1.738
Sell
MA20
1.799
Sell
MA50
1.830
Sell
MA100
2.075
Sell
MA200
2.129
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Microbot Medical Inc Info

Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Ticker SymbolMBOT
CompanyMicrobot Medical Inc
CEOGadot (Harel)
Websitehttp://www.microbotmedical.com/

Shareholders

Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
4.33%
CIBC Private Wealth Advisors, Inc.
2.78%
Susquehanna International Group, LLP
1.85%
UBS Financial Services, Inc.
1.22%
BlackRock Institutional Trust Company, N.A.
1.21%
Other
88.60%

FAQs

What is the current price of Microbot Medical Inc (MBOT)?

The current price of Microbot Medical Inc (MBOT) is 1.72.

What is the symbol of Microbot Medical Inc?

The ticker symbol of Microbot Medical Inc is MBOT.

What is the 52-week high of Microbot Medical Inc?

The 52-week high of Microbot Medical Inc is 4.67.

What is the 52-week low of Microbot Medical Inc?

The 52-week low of Microbot Medical Inc is 1.60.

What is the market capitalization of Microbot Medical Inc?

The market capitalization of Microbot Medical Inc is 115.51M.

Is Microbot Medical Inc (MBOT) currently rated as Buy, Hold, or Sell?

According to analysts, Microbot Medical Inc (MBOT) has an overall rating of Buy, with a price target of 7.00.

What is the Earnings Per Share (EPS TTM) of Microbot Medical Inc (MBOT)?

The Earnings Per Share (EPS TTM) of Microbot Medical Inc (MBOT) is -0.29.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.